Provided by Tiger Trade Technology Pte. Ltd.

Zoetis

69.83
-0.4700-0.67%
Post-market: 69.990.1600+0.23%19:58 EDT
Volume:4.44M
Turnover:310.95M
Market Cap:28.86B
PE:11.43
High:70.77
Open:70.55
Low:69.52
Close:70.30
52wk High:148.79
52wk Low:69.52
Shares:413.22M
Float Shares:412.00M
Volume Ratio:1.18
T/O Rate:1.08%
Dividend:2.06
Dividend Rate:2.95%
EPS(TTM):6.11
EPS(LYR):6.02
ROE:64.91%
ROA:15.35%
PB:9.17
PE(LYR):11.60

Loading ...

Zoetis Inc. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Jul 31

Zoetis Says UK Regulator Approves Portela for Cat Osteoarthritis Pain

Reuters
·
Jul 30

NYSE Order Imbalance 606104.0 Shares on Buy Side

THOMSON REUTERS
·
Jul 30

Analysts Conflicted on These Healthcare Names: BioMarin Pharmaceutical (BMRN), Zoetis (ZTS) and Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Jul 28

Zoetis Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 28

Zoetis is Maintained at Neutral by UBS

Dow Jones
·
Jul 28

Elanco Seems Best-Positioned Into Q2 Print Among Animal Health Stocks, UBS Says

MT Newswires Live
·
Jul 28

UBS Adjusts Zoetis Price Target to $85 From $99, Maintains Neutral Rating

MT Newswires Live
·
Jul 27

Zoetis price target lowered to $85 from $99 at UBS

TIPRANKS
·
Jul 27

Zoetis Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 25

NYSE Order Imbalance 423852.0 Shares on Buy Side

THOMSON REUTERS
·
Jul 24

Zoetis Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Jul 23

Zoetis is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Jul 23

Morgan Stanley Adjusts Price Target on Zoetis to $99 From $115, Maintains Overweight Rating

MT Newswires Live
·
Jul 22

Zoetis Inc. : Morgan Stanley Cuts Target Price to $99.00 from $115.00

THOMSON REUTERS
·
Jul 22

Zoetis launches Portela in Canada, the EU

TIPRANKS
·
Jul 22

Zoetis Launches Portela® (relfovetmab) in Canada and the European Union

THOMSON REUTERS
·
Jul 22

Zoetis Inc. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Jul 22

Unusually active option classes on open July 20th

TIPRANKS
·
Jul 20

Australia's ACCC Says Zoetis' Acquisition of Neogen Genomics Requires Phase 2 Review

Reuters
·
Jul 17